Dr. Nazar Kalivoshko, MD

Dr. Kalivoshko practices at Prisma Health Hillcrest Hospital in Simpsonville, South Carolina, part of Prisma Health.

Dr. Kalivoshko's NPI, 1932148830, was assigned on June 6, 2006. Dr. Kalivoshko holds Ohio license 35.122864.

Dr. Kalivoshko's primary practice is Prisma Health Hillcrest Hospital, at 741 South East Main Street, Simpsonville, SC 29681 in Greenville County. The practice phone is (864) 454-6100. Dr. Kalivoshko also practices at Hillcrest Hospital, 6780 Mayfield Rd, Cleveland, OH 44124.

Dr. Kalivoshko's primary practice is Prisma Health Hillcrest Hospital in Simpsonville, South Carolina, part of Prisma Health. Dr. Kalivoshko is also affiliated with Hillcrest Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Kalivoshko to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalivoshko practices, 5 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Kalivoshko's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dmand AI has Dr. Kalivoshko's licenses on file in 2 states: Ohio and New York.

CMS data shows 123 Medicare services from Dr. Kalivoshko across 8 procedure codes in 2024, for 250 Medicare patients. Medicare paid $10,743 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 250 Medicare patients who saw Dr. Kalivoshko in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalivoshko's median patient age at 59, with 64% women.

Dr. Kalivoshko accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 41 general payments to Dr. Kalivoshko from 7 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 59% of the total. Halyard Health, Inc. paid the most, $33,028.